Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Potentially Profound Fluctuation in Tacrolimus Concentration on the Consumption of Pomegranate: Computed by Lc-Ms/Ms and Md Simulation Studies

View through CrossRef
Presently, varied case reports demonstrated an increase or decrease in blood concentration of diverse conventional drugs, often co-administered with edible fruits, spices, or vegetables. The overarching aim of this research is to elucidate the fluctuations in tacrolimus (TAC) blood concentration on the consumption of pomegranate rind extract (PG). Pharmacokinetic (PK) study was conducted with two groups, viz-a-viz PG (200 mg/kg) + TAC (2mg/kg) and TAC (3mg/kg) alone group. For this, the PG (200 mg/kg) was given to the Wistar rats on day 0 and continued till 6 days. On the 7th day, respective doses of TAC were administered orally, in rats 1 hr after oral administration of the PG. All the blood samples (approximately 300 μl) were withdrawn at diverse time intervals i.e. 30 min, 1 hr, 2hr, 4hr, 8hr, and 12hr after oral administration of TAC. Estimation of TAC in rat plasma was done by using the hyphenated technique LC-MS/MS where the mass spectrometer used was triple-stage quadruple and using multiple reactions monitoring (MRM) mode. Findings depict that on comparison with TAC (3mg/kg) alone group, the Cmax was found to be 4.34±0.60 ng/ml; AUC from time zero to infinity (AUC0-∞), 31.58±1.47 ngh/ml, whilst TAC (2mg/kg)+ PG group exhibited an increase in PK parameters of TAC (Cmax 15.08±1.56 ng/ml; AUC0-∞69.38±3.68 ng h/ml). The authors further investigated in what manner the PG affects the PK of TAC in animals. For this, a CYP3A4 inhibitory assay was conducted, and to validate our findings, docking studies with selected phytoconstituents and CYP3A4 isoenzyme was carried out. Ellagitannins (dock score -11.64) and punicalagin (dock score -10.68) were again used for molecular simulation studies with TAC. Based on integrated in-vivo and in-silico studies, we concluded that punicalagin interacts strongly with CYP isoenzyme, and therefore responsible for the altered PK profile of TAC.
Title: Potentially Profound Fluctuation in Tacrolimus Concentration on the Consumption of Pomegranate: Computed by Lc-Ms/Ms and Md Simulation Studies
Description:
Presently, varied case reports demonstrated an increase or decrease in blood concentration of diverse conventional drugs, often co-administered with edible fruits, spices, or vegetables.
The overarching aim of this research is to elucidate the fluctuations in tacrolimus (TAC) blood concentration on the consumption of pomegranate rind extract (PG).
Pharmacokinetic (PK) study was conducted with two groups, viz-a-viz PG (200 mg/kg) + TAC (2mg/kg) and TAC (3mg/kg) alone group.
For this, the PG (200 mg/kg) was given to the Wistar rats on day 0 and continued till 6 days.
On the 7th day, respective doses of TAC were administered orally, in rats 1 hr after oral administration of the PG.
All the blood samples (approximately 300 μl) were withdrawn at diverse time intervals i.
e.
30 min, 1 hr, 2hr, 4hr, 8hr, and 12hr after oral administration of TAC.
Estimation of TAC in rat plasma was done by using the hyphenated technique LC-MS/MS where the mass spectrometer used was triple-stage quadruple and using multiple reactions monitoring (MRM) mode.
Findings depict that on comparison with TAC (3mg/kg) alone group, the Cmax was found to be 4.
34±0.
60 ng/ml; AUC from time zero to infinity (AUC0-∞), 31.
58±1.
47 ngh/ml, whilst TAC (2mg/kg)+ PG group exhibited an increase in PK parameters of TAC (Cmax 15.
08±1.
56 ng/ml; AUC0-∞69.
38±3.
68 ng h/ml).
The authors further investigated in what manner the PG affects the PK of TAC in animals.
For this, a CYP3A4 inhibitory assay was conducted, and to validate our findings, docking studies with selected phytoconstituents and CYP3A4 isoenzyme was carried out.
Ellagitannins (dock score -11.
64) and punicalagin (dock score -10.
68) were again used for molecular simulation studies with TAC.
Based on integrated in-vivo and in-silico studies, we concluded that punicalagin interacts strongly with CYP isoenzyme, and therefore responsible for the altered PK profile of TAC.

Related Results

Ranolazine-Tacrolimus Interaction
Ranolazine-Tacrolimus Interaction
Objective: To report the case of a kidney allograft recipient on a stable regimen of tacrolimus who exhibited increased tacrolimus concentrations within 24 hour...
Tacrolimus and Mycophenolate Mofetil Provide Effective Immunosuppression in Rat Laryngeal Transplantation
Tacrolimus and Mycophenolate Mofetil Provide Effective Immunosuppression in Rat Laryngeal Transplantation
AbstractObjectives/Hypothesis Tacrolimus is efficacious in several transplantation settings. Some studies have demonstrated improved results using combination therapy with mycophen...
Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale
Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale
Le rein est particulièrement exposé à de nombreux composés chimiques dont des médicaments, potentiellement néphrotoxiques. Parmi-eux, le Tacrolimus, un anti-calcineurine largement ...
The Impact of CYP3A5 Genotype on Tacrolimus Pharmacokinetics in Children following Heart Transplant
The Impact of CYP3A5 Genotype on Tacrolimus Pharmacokinetics in Children following Heart Transplant
Abstract Tacrolimus is a first-line immunosuppressant used after solid organ transplantation that suffers from extensive intra- and inter-patient variability and a ...
Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells
Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells
Background Topical tacrolimus has been used for vitiligo as a common treatment option for more than ten years while the underlying mechanism is still uncertain. The aim...
Sex differences in response to chronic administration of Tacrolimus in spontaneously hypertensive rats
Sex differences in response to chronic administration of Tacrolimus in spontaneously hypertensive rats
Hypertension in male spontaneously hypertensive rats (SHR) is thought to be mediated in part by enhanced immune function. Tacrolimus (FK‐506) is a potent immunosuppressive used to ...

Back to Top